Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

NCT00176800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Carcinoma

Interventions

DRUG: Tetrathiomolybdate (TM)
PROCEDURE: Radiation
PROCEDURE: Surgery

Sponsor

University of Michigan Rogel Cancer Center